Cell Separation Market through Biomolecule Isolation Application to grow at a CAGR of around 31% in Next 10 Years, States Persistence Market Research
January 17, 2023 09:30 ET
|
Persistence Market Research
New York, Jan. 17, 2023 (GLOBE NEWSWIRE) -- According to the study, the global Cell Separation Market was valued at US$ 8.1 Bn in 2021, and it is also expected to expand at a CAGR of 25.5% over the...
Patient-derived Xenograft Model Global Market Report 2022: Rising Cancer Cases and R&D by Pharmaceutical Companies Fuel Growth
December 28, 2022 07:13 ET
|
Research and Markets
Dublin, Dec. 28, 2022 (GLOBE NEWSWIRE) -- The "Patient-derived Xenograft Model Market Size, Share & Trends Analysis Report By Tumor Type (Lung, Pancreatic), By Model Type (Rats, Mice), By...
Global 3D Cell Culture Market to Gather $5,656.7 Million by 2031, Growing at a CAGR of 15.07% in the 2022-2031 Timeframe Report [200-Pages] by Research Dive
December 27, 2022 09:01 ET
|
Research Dive
New York, USA, Dec. 27, 2022 (GLOBE NEWSWIRE) -- According to the latest report published by Research Dive, the global 3D cell culture market is expected to gather a revenue of $5,656.7 million by...
Cell Culture Global Market Report 2022: Industry to Reach $48.63 Billion by 2029 at a CAGR of 11.7%
December 22, 2022 04:58 ET
|
Research and Markets
Dublin, Dec. 22, 2022 (GLOBE NEWSWIRE) -- The "Cell Culture Market by Product [Consumables (Media, Reagents, Sera, Cell Lines), Equipment (Bioreactor, Centrifuge, Cell Counter)], Application...
OmicsVeu Launches An Extensive Line Of Spatial Biology Products For Multiplex Multi-omics
December 13, 2022 07:05 ET
|
BioGenex
Fremont, Dec. 13, 2022 (GLOBE NEWSWIRE) -- OmicsVeu, a wholly owned subsidiary of BioGenex, is pleased to announce the launch of a broad line of Multiplex Multi-Omics products for spatial biology...
Sermonix Shares Two Posters at SABCS 2022 on ER+/HER2- Metastatic Breast Cancer Patient Survey About Knowledge of NGS and ESR1 Mutations, Quality of Life Concerns
December 09, 2022 08:00 ET
|
Sermonix Pharmaceuticals Inc.
SAN ANTONIO, Dec. 09, 2022 (GLOBE NEWSWIRE) -- Sermonix Pharmaceuticals Inc., a privately held biopharmaceutical company developing innovative targeted therapeutics to specifically treat...
Breast Cancer Canada announces $500K in new grant funding
December 01, 2022 13:58 ET
|
Breast Cancer Canada
SARNIA, Ontario, Dec. 01, 2022 (GLOBE NEWSWIRE) -- Breast Cancer Canada today announced a call for proposals for their 2023 Precision Oncology Research Grants which will award $500,000 in new...
Immuno-oncology Global Market Report 2022: Approval of Novel Therapies Boosts Sector Growth
November 30, 2022 05:48 ET
|
Research and Markets
Dublin, Nov. 30, 2022 (GLOBE NEWSWIRE) -- The "Immuno-oncology Market Size, Share, Trends, Analysis and Forecast by Region, Segment, Type (Checkpoint Modulators, Cancer Vaccines) and End-User...
Sunshine Biopharma Enters Into a Collaboration Agreement with a Leading Lipid Nanoparticle Formulation Company for Its K1.1 Anticancer mRNA Project
November 16, 2022 08:00 ET
|
Sunshine Biopharma Inc.
MONTREAL, Nov. 16, 2022 (GLOBE NEWSWIRE) -- Sunshine Biopharma Inc. (NASDAQ: “SBFM”), a pharmaceutical company offering and researching life-saving medicines in a variety of therapeutic areas,...
FRED’S TEAM MAKES HISTORY BY RAISING $100 MILLION FOR CANCER RESEARCH
November 03, 2022 09:00 ET
|
Memorial Sloan Kettering Cancer Center
NEW YORK, Nov. 03, 2022 (GLOBE NEWSWIRE) -- Fred’s Team, MSK’s running program, has made history by surpassing $100 million in total funds raised for cancer research. Since 1995, runners have joined...